Genome trimming: a unique strategy for replication control employed by Borna disease virus.
Genome and antigenome synthesis of negative-strand RNA viruses is initiated at promoters located in inverted terminal repeats (ITR). The ITR of Borna disease virus (BDV), a persisting neurotropic virus with a nuclear replication phase, are exceptional in that they appear to be noncomplete. Our analysis showed that the vast majority of genomic and antigenomic RNA molecules of BDV lack four 5'-terminal nucleotides required for perfect complementarity with the 3' ITR. By using a previously undescribed reverse genetics system, we investigated whether the structure of the ITR would affect virus propagation. BDV rescued from cDNA encoding complete ITR (rBDVc) showed wild-type virulence, whereas virus rescued from cDNA encoding a viral genome with noncomplete ITR (rBDVnc) was strongly attenuated. Both recombinant viruses expressed similar RNA and protein levels in persistently infected cells. However, rBDVnc particles were less infectious, indicating that complete ITR are required for high viral replicase but not transcriptase activity. Interestingly, genomic RNA from purified rBDVc particles lacked 5'-terminal nucleotides like authentic BDV, strongly suggesting programmed genome truncation. By specifically trimming its genome at the 5' terminus, BDV seems to limit viral genome amplification, which may favor noncytolytic viral persistence.
Schneider
Urs
U
Abteilung Virologie, Institut für Medizinische Mikrobiologie and Hygiene, Universität Freiburg, D-79104 Freiburg, Germany. urs.schneider@uniklinik-freiburg.de
Schwemmle
Martin
M
Staeheli
Peter
P
D001483:Base Sequence; D001891:Borna disease virus / Q000235:genetics / Q000502:physiology*; D017931:DNA Primers; D016679:Genome, Viral; D008856:Microscopy, Fluorescence; D008969:Molecular Sequence Data; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014779:Virus Replication
D017931:DNA Primers
J Virol. 2000 Feb;74(3):1321-31
10627543
J Virol. 1994 Oct;68(10):6514-22
8083989
J Virol. 2001 Jul;75(14):6418-27
11413309
J Gen Virol. 2001 Nov;82(Pt 11):2681-90
11602780
Front Biosci. 2002 Feb 1;7:d569-79
11815302
Front Biosci. 2002 Mar 1;7:d593-607
11861216
Biol Psychiatry. 2002 Jun 15;51(12):979-87
12062882
J Infect Dis. 2002 Dec 1;186 Suppl 2:S241-7
12424704
J Virol. 2003 Nov;77(21):11781-9
14557662
J Gen Virol. 2003 Nov;84(Pt 11):3099-104
14573815
J Virol. 2004 Feb;78(3):1129-38
14722268
Curr Top Microbiol Immunol. 1995;190:17-30
7789148
Virology. 1995 Jun 20;210(1):1-8
7793061
J Virol. 1995 Sep;69(9):5754-62
7637020
J Virol. 1996 Nov;70(11):7713-24
8892892
Virology. 1996 Nov 1;225(1):163-71
8918543
J Virol. 1998 May;72(5):4528-33
9557754
Annu Rev Genet. 1998;32:123-62
9928477
Nucleic Acids Res. 1999 Mar 1;27(5):1392-7
9973631
Proc Natl Acad Sci U S A. 1970 Oct;67(2):921-8
5289029
Virus Res. 1985 Feb;2(1):29-33
3920840
Virology. 1987 Sep;160(1):191-202
3629974
Proc Natl Acad Sci U S A. 1987 Nov;84(22):8140-4
2446318
Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11486-9
1454837
J Virol. 1994 Mar;68(3):1371-81
8107202
J Virol. 1994 Mar;68(3):1382-96
7906311
Proc Natl Acad Sci U S A. 1994 May 10;91(10):4362-6
8183914
Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8587-91
8078927
J Gen Virol. 2000 Sep;81(Pt 9):2123-35
10950968